Fusion Pharmaceuticals Inc.
FUSN · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$33,670 | -$28,179 | -$17,252 | -$25,175 |
| Dep. & Amort. | $361 | $361 | $374 | $337 |
| Deferred Tax | -$405 | $2,918 | -$882 | -$696 |
| Stock-Based Comp. | $4,517 | $3,255 | $2,994 | $3,046 |
| Change in WC | $2,346 | $3,011 | -$4,252 | $3,456 |
| Other Non-Cash | $4,332 | $1,699 | $179 | -$552 |
| Operating Cash Flow | -$27,306 | -$16,935 | -$18,839 | -$19,584 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,334 | -$1,439 | -$473 | -$710 |
| Net Acquisitions | $0 | -$48,914 | -$13,799 | $25,609 |
| Inv. Purchases | -$118,607 | -$56,430 | -$38,829 | -$70,082 |
| Inv. Sales/Matur. | $49,570 | $53,171 | $52,628 | $44,473 |
| Other Inv. Act. | -$69,037 | $48,914 | $13,799 | -$25,609 |
| Investing Cash Flow | -$70,371 | -$4,697 | $13,326 | -$26,319 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $49,096 | $56,216 | $45 | $24,442 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $64,011 | $57,855 | $328 | $24,308 |
| Financing Cash Flow | $64,011 | $56,216 | $328 | $24,308 |
| Forex Effect | $0 | $85 | $0 | $0 |
| Net Chg. in Cash | -$33,666 | $34,669 | -$5,185 | -$21,595 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $61,925 | $27,256 | $33,290 | $54,885 |
| End Cash | $28,259 | $61,925 | $28,105 | $33,290 |
| Free Cash Flow | -$28,640 | -$18,374 | -$19,312 | -$20,294 |